Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Xeris Biopharma Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 10,000 shares
@ $2.3794, valued at
$23.8k
|
|
| 06/07/2023 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| Kong Garheng (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| PERSKY MARLA (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/07/2023 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 20,000 shares
@ $1.45, valued at
$29k
|
|
| 06/09/2022 |
4
| Kong Garheng (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $2.1, valued at
$31.5k
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| PERSKY MARLA (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| Schmid John P. (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 06/09/2022 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 25,000 options to buy
@ $2.1, valued at
$52.5k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Pieper Steven (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 01/05/2022 |
4
| JOHNSON KENNETH ERLAND (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 01/05/2022 |
4
| Hecht Beth (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 01/05/2022 |
4
| Shannon John Patrick Jr (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 01/05/2022 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 600,000 shares
@ $0 |
|
| 01/05/2022 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 11/16/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 20,000 shares
@ $2.2832, valued at
$45.7k
|
|
| 11/12/2021 |
4
| Shannon John Patrick Jr (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 40,000 shares
@ $2.0875, valued at
$83.5k
Bought 60,000 shares
@ $2.1, valued at
$126k
|
|
| 11/12/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 200,000 shares
@ $2.0788, valued at
$415.8k
|
|
|
|
|